Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Biophytis To Restart Recruitment In US Centers For COVID-19 Trial
November 15, 2021
Tickers
BPTS
From Benzinga
EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate
November 15, 2021
Tickers
NNVC
From Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
November 12, 2021
From Benzinga
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
November 12, 2021
From Benzinga
From Benzinga
EU Lists Spinal Cord Inflammation Probable Side Effect Of JNJ's COVID-19 Shot: Reuters
November 11, 2021
From Benzinga
Moderna Says COVID-19 Vax Associated With Fewer Cases Than Pfizer's, But Higher Inflammatory Heart Conditions
November 11, 2021
From Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
November 11, 2021
From Benzinga
Moderna, NIH At Odds Over Who Invented The Biotech's COVID-19 Shot: NYT
November 10, 2021
Tickers
MRNA
From Benzinga
Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
November 10, 2021
From Benzinga
GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate
November 10, 2021
From Benzinga
AstraZeneca Plans To Set Up Separate Division For Vaccines & Antibody Therapies - Report
November 10, 2021
From Benzinga
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial
November 09, 2021
Tickers
INO
From Benzinga
US Government To Purchase Additional 1.4M Doses Of Merck's COVID-19 Pill
November 09, 2021
Tickers
MRK
From Benzinga
BioNTech Clocks Q3 Sales Of €6B; Raises FY21 COVID-19 Vax Sales Outlook
November 09, 2021
From Benzinga
Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters
November 08, 2021
From Benzinga
Amyris, ImmunityBio Join Forces For Next-Gen COVID-19 RNA Vaccine
November 08, 2021
From Benzinga
From Benzinga
See Why Emergent BioSolutions Stock Plunged 37% On Friday?
November 05, 2021
From Benzinga
Ocugen Seeks FDA Emergency Use Nod For Covaxin COVID-19 Vaccine In Kids
November 05, 2021
Tickers
OCGN
From Benzinga
NRx Pharma Stock Nosedives As FDA Strikes Off Its COVID-19 Drug Hopeful
November 05, 2021
From Benzinga
Pfizer Touts Encouraging Data For Its COVID-19 Oral Antiviral, With 89% Reduction In Hospitalization, Death
November 05, 2021
From Benzinga
Britain Approves First Oral COVID-19 Antiviral From Merck
November 04, 2021
Tickers
MRK
From Benzinga
Ocugen's India Partnered COVID-19 Vaccine Gets WHO Approval: Report
November 03, 2021
Tickers
OCGN
From Benzinga
FDA Authorizes OraSure's COVID-19 Rapid Tests For OTC Single-Use
November 02, 2021
Tickers
OSUR
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.